发表研究结果有使用 ab80?请让我们知道,以便我们可以引用本数据表中的参考文章。

ab80 被引用在 181 文献中.

  • Ritschka B  et al. The senescence-associated secretory phenotype induces cellular plasticity and tissue regeneration. Genes Dev 31:172-183 (2017). PubMed: 28143833
  • El Shahawy M  et al. Cell fate specification in the lingual epithelium is controlled by antagonistic activities of Sonic hedgehog and retinoic acid. PLoS Genet 13:e1006914 (2017). PubMed: 28715412
  • Zhang S  et al. lncRNA Up-Regulated in Nonmuscle Invasive Bladder Cancer Facilitates Tumor Growth and Acts as a Negative Prognostic Factor of Recurrence. J Urol 196:1270-8 (2016). PubMed: 27267320
  • Ding X  et al. Synthetic viability by BRCA2 and PARP1/ARTD1 deficiencies. Nat Commun 7:12425 (2016). WB ; Mouse . PubMed: 27498558
  • Delbridge AR  et al. RAG-induced DNA lesions activate proapoptotic BIM to suppress lymphomagenesis in p53-deficient mice. J Exp Med 213:2039-48 (2016). PubMed: 27621418
  • Xia N  et al. SENP1 Is a Crucial Regulator for Cell Senescence through DeSUMOylation of Bmi1. Sci Rep 6:34099 (2016). PubMed: 27659494
  • Lee H  et al. BAF180 regulates cellular senescence and hematopoietic stem cell homeostasis through p21. Oncotarget 7:19134-46 (2016). WB . PubMed: 26992241
  • Borland G  et al. Addiction to Runx1 is partially attenuated by loss of p53 in the Eµ-Myc lymphoma model. Oncotarget 7:22973-87 (2016). WB . PubMed: 27056890
  • Wang L  et al. Mitogen-activated protein kinase kinase 3 induces cell cycle arrest via p38 activation mediated Bmi-1 downregulation in hepatocellular carcinoma. Mol Med Rep 13:243-8 (2016). PubMed: 26573508
  • Page A  et al. Protective role of p53 in skin cancer: Carcinogenesis studies in mice lacking epidermal p53. Oncotarget 7:20902-18 (2016). WB, IHC . PubMed: 26959115
  • Jiang D  et al. Comparison of effects of p53 null and gain-of-function mutations on salivary tumors in MMTV-Hras transgenic mice. PLoS One 10:e0118029 (2015). PubMed: 25695772
  • Jullien N  et al. Dose-dependent dual role of PIT-1 (POU1F1) in somatolactotroph cell proliferation and apoptosis. PLoS One 10:e0120010 (2015). WB . PubMed: 25822178
  • Ito T  et al. Impact of taurine depletion on glucose control and insulin secretion in mice. J Pharmacol Sci 129:59-64 (2015). PubMed: 26382103
  • Leikam C  et al. In vitro evidence for senescent multinucleated melanocytes as a source for tumor-initiating cells. Cell Death Dis 6:e1711 (2015). PubMed: 25837487
  • Wang H  et al. Turning terminally differentiated skeletal muscle cells into regenerative progenitors. Nat Commun 6:7916 (2015). Newt . PubMed: 26243583
  • Lu Y  et al. CDK4 deficiency promotes genomic instability and enhances Myc-driven lymphomagenesis. J Clin Invest 124:1672-84 (2014). WB . PubMed: 24614102
  • Kanatsu-Shinohara M  et al. Skp1-Cullin-F-box (SCF)-type ubiquitin ligase FBXW7 negatively regulates spermatogonial stem cell self-renewal. Proc Natl Acad Sci U S A 111:8826-31 (2014). IHC-Fr ; Mouse . PubMed: 24879440
  • Kharabi Masouleh B  et al. Mechanistic rationale for targeting the unfolded protein response in pre-B acute lymphoblastic leukemia. Proc Natl Acad Sci U S A 111:E2219-28 (2014). PubMed: 24821775
  • Britigan EM  et al. The ARF tumor suppressor prevents chromosomal instability and ensures mitotic checkpoint fidelity through regulation of Aurora B. Mol Biol Cell 25:2761-73 (2014). PubMed: 25057018
  • Grenier K  et al. Short mitochondrial ARF triggers Parkin/PINK1-dependent mitophagy. J Biol Chem 289:29519-30 (2014). PubMed: 25217637
  • Santos M  et al. In vivo disruption of an Rb-E2F-Ezh2 signaling loop causes bladder cancer. Cancer Res 74:6565-77 (2014). PubMed: 25252918
  • Sakai H  et al. Wild-type p53-induced phosphatase 1 (Wip1) forestalls cellular premature senescence at physiological oxygen levels by regulating DNA damage response signaling during DNA replication. Cell Cycle 13:1015-29 (2014). WB . PubMed: 24552809
  • Iqbal N  et al. miR-34a is essential for p19(Arf)-driven cell cycle arrest. Cell Cycle 13:792-800 (2014). PubMed: 24401748
  • Iqbal NS  et al. Isolation and characterization of mammalian cells expressing the Arf promoter during eye development. Biotechniques 56:239-49 (2014). PubMed: 24806224
  • Luo C  et al. Loss of ARF sensitizes transgenic BRAFV600E mice to UV-induced melanoma via suppression of XPC. Cancer Res 73:4337-48 (2013). PubMed: 23650282
  • Burd CE  et al. Monitoring tumorigenesis and senescence in vivo with a p16(INK4a)-luciferase model. Cell 152:340-51 (2013). PubMed: 23332765
  • Robinson GL  et al. Akt signaling accelerates tumor recurrence following ras inhibition in the context of ink4a/arf loss. Genes Cancer 4:476-85 (2013). PubMed: 24386508
  • Shamma A  et al. ATM mediates pRB function to control DNMT1 protein stability and DNA methylation. Mol Cell Biol 33:3113-24 (2013). PubMed: 23754744
  • Heideman MR  et al. Dosage-dependent tumor suppression by histone deacetylases 1 and 2 through regulation of c-Myc collaborating genes and p53 function. Blood 121:2038-50 (2013). WB . PubMed: 23327920
  • Haupt S  et al. Loss of PML cooperates with mutant p53 to drive more aggressive cancers in a gender-dependent manner. Cell Cycle 12:1722-31 (2013). Mouse . PubMed: 23656786
  • Budina-Kolomets A  et al. A conserved domain in exon 2 coding for the human and murine ARF tumor suppressor protein is required for autophagy induction. Autophagy 9:1553-65 (2013). WB, ICC/IF . PubMed: 23939042
  • Tokarsky-Amiel R  et al. Dynamics of senescent cell formation and retention revealed by p14ARF induction in the epidermis. Cancer Res 73:2829-39 (2013). PubMed: 23423975
  • Odell AF  et al. A novel p53 mutant found in iatrogenic urothelial cancers is dysfunctional and can be rescued by a second-site global suppressor mutation. J Biol Chem 288:16704-14 (2013). PubMed: 23612969
  • Huggins CJ  et al. C/EBP? suppresses senescence and inflammatory gene expression by heterodimerizing with C/EBPß. Mol Cell Biol 33:3242-58 (2013). IP ; Mouse . PubMed: 23775115
  • Alexandrova EM  et al. ?Np63 regulates select routes of reprogramming via multiple mechanisms. Cell Death Differ 20:1698-708 (2013). WB . PubMed: 24013722
  • Storer M  et al. Senescence is a developmental mechanism that contributes to embryonic growth and patterning. Cell 155:1119-30 (2013). IHC-P ; Mouse . PubMed: 24238961
  • Xie C  et al. RUVBL2 is a novel repressor of ARF transcription. FEBS Lett 586:435-41 (2012). PubMed: 22285491
  • Zoumpoulidou G  et al. Role of the tripartite motif protein 27 in cancer development. J Natl Cancer Inst 104:941-52 (2012). PubMed: 22556269
  • Wei QX  et al. Efficient introduction of specific TP53 mutations into mouse embryonic fibroblasts and embryonic stem cells. Nat Protoc 7:1145-60 (2012). WB, ICC/IF ; Mouse . PubMed: 22596227
  • Widau RC  et al. p19Arf represses platelet-derived growth factor receptor ß by transcriptional and posttranscriptional mechanisms. Mol Cell Biol 32:4270-82 (2012). PubMed: 22907756
  • O'Dell MR  et al. Kras(G12D) and p53 mutation cause primary intrahepatic cholangiocarcinoma. Cancer Res 72:1557-67 (2012). PubMed: 22266220
  • Ko A  et al. Acceleration of gastric tumorigenesis through MKRN1-mediated posttranslational regulation of p14ARF. J Natl Cancer Inst 104:1660-72 (2012). PubMed: 23104211
  • Mallette FA & Richard S JMJD2A promotes cellular transformation by blocking cellular senescence through transcriptional repression of the tumor suppressor CHD5. Cell Rep 2:1233-43 (2012). PubMed: 23168260
  • Caldwell ME  et al. Cellular features of senescence during the evolution of human and murine ductal pancreatic cancer. Oncogene 31:1599-608 (2012). PubMed: 21860420
  • Migliorini D  et al. Cop1 constitutively regulates c-Jun protein stability and functions as a tumor suppressor in mice. J Clin Invest 121:1329-43 (2011). PubMed: 21403399
  • Ying H  et al. PTEN is a major tumor suppressor in pancreatic ductal adenocarcinoma and regulates an NF-?B-cytokine network. Cancer Discov 1:158-69 (2011). WB . PubMed: 21984975
  • Pathak S  et al. IRF4 is a suppressor of c-Myc induced B cell leukemia. PLoS One 6:e22628 (2011). PubMed: 21818355
  • Vanbrocklin MW  et al. Ink4a/Arf loss promotes tumor recurrence following Ras inhibition. Neuro Oncol : (2011). PubMed: 22015595
  • Song MS  et al. Nuclear PTEN regulates the APC-CDH1 tumor-suppressive complex in a phosphatase-independent manner. Cell 144:187-99 (2011). WB ; Mouse . PubMed: 21241890
  • Herkert B  et al. The Arf tumor suppressor protein inhibits Miz1 to suppress cell adhesion and induce apoptosis. J Cell Biol 188:905-18 (2010). WB ; Mouse . PubMed: 20308430
  • Lacroix M  et al. Transcription factor E4F1 is essential for epidermal stem cell maintenance and skin homeostasis. Proc Natl Acad Sci U S A 107:21076-81 (2010). WB ; Mouse . PubMed: 21088222
  • Robinson JP  et al. Activated BRAF induces gliomas in mice when combined with Ink4a/Arf loss or Akt activation. Oncogene 29:335-44 (2010). IHC-P ; Mouse . PubMed: 19855433
  • VanBrocklin MW  et al. Targeted delivery of NRASQ61R and Cre-recombinase to post-natal melanocytes induces melanoma in Ink4a/Arflox/lox mice. Pigment Cell Melanoma Res 23:531-41 (2010). IHC ; Mouse . PubMed: 20444198
  • Manning JA & Kumar S A potential role for NEDD1 and the centrosome in senescence of mouse embryonic fibroblasts. Cell Death Dis 1:e35 (2010). WB . PubMed: 21364642
  • Takeuchi S  et al. Intrinsic cooperation between p16INK4a and p21Waf1/Cip1 in the onset of cellular senescence and tumor suppression in vivo. Cancer Res 70:9381-90 (2010). PubMed: 21062974
  • Dean JL  et al. Modeling the effect of the RB tumor suppressor on disease progression: dependence on oncogene network and cellular context. Oncogene 29:68-80 (2010). PubMed: 19802012
  • Kamata T  et al. BRAF inactivation drives aneuploidy by deregulating CRAF. Cancer Res 70:8475-86 (2010). PubMed: 20978199
  • Ta VB  et al. Malignant transformation of Slp65-deficient pre-B cells involves disruption of the Arf-Mdm2-p53 tumor suppressor pathway. Blood 115:1385-93 (2010). PubMed: 20008789
  • Wilting RH  et al. Overlapping functions of Hdac1 and Hdac2 in cell cycle regulation and haematopoiesis. EMBO J 29:2586-97 (2010). PubMed: 20571512
  • Monahan KB  et al. Somatic p16(INK4a) loss accelerates melanomagenesis. Oncogene 29:5809-17 (2010). WB . PubMed: 20697345
  • Negishi M  et al. A novel zinc finger protein Zfp277 mediates transcriptional repression of the Ink4a/arf locus through polycomb repressive complex 1. PLoS One 5: (2010). WB . PubMed: 20808772
  • Malhas A  et al. The nuclear envelope can control gene expression and cell cycle progression via miRNA regulation. Cell Cycle 9:531-9 (2010). PubMed: 20081371
  • Freeman-Anderson NE  et al. Expression of the Arf tumor suppressor gene is controlled by Tgfbeta2 during development. Development 136:2081-9 (2009). PubMed: 19465598
  • Inuzuka Y  et al. Suppression of phosphoinositide 3-kinase prevents cardiac aging in mice. Circulation 120:1695-703 (2009). PubMed: 19822807
  • Djojosubroto M  et al. Chromosomal number aberrations and transformation in adult mouse retinal stem cells in vitro. Invest Ophthalmol Vis Sci 50:5975-87 (2009). PubMed: 19628750
  • Brady SN  et al. Nucleophosmin protein expression level, but not threonine 198 phosphorylation, is essential in growth and proliferation. Oncogene 28:3209-20 (2009). WB . PubMed: 19561638
  • Tchougounova E  et al. Sox5 can suppress platelet-derived growth factor B-induced glioma development in Ink4a-deficient mice through induction of acute cellular senescence. Oncogene 28:1537-48 (2009). WB ; Mouse . PubMed: 19219070
  • Sebastian T & Johnson PF RasV12-mediated down-regulation of CCAAT/enhancer binding protein beta in immortalized fibroblasts requires loss of p19Arf and facilitates bypass of oncogene-induced senescence. Cancer Res 69:2588-98 (2009). WB ; Mouse . PubMed: 19276382
  • Bieging KT  et al. Epstein-Barr virus LMP2A bypasses p53 inactivation in a MYC model of lymphomagenesis. Proc Natl Acad Sci U S A : (2009). WB ; Mouse . PubMed: 19815507
  • Kawamura T  et al. Linking the p53 tumour suppressor pathway to somatic cell reprogramming. Nature 460:1140-4 (2009). WB ; Mouse . PubMed: 19668186
  • Nepal RM  et al. Msh2-dependent DNA repair mitigates a unique susceptibility of B cell progenitors to c-Myc-induced lymphomas. Proc Natl Acad Sci U S A 106:18698-703 (2009). WB ; Mouse . PubMed: 19837692
  • Pan D  et al. SnoN functions as a tumour suppressor by inducing premature senescence. EMBO J : (2009). WB, ICC/IF ; Mouse . PubMed: 19745809
  • Kranc KR  et al. Cited2 is an essential regulator of adult hematopoietic stem cells. Cell Stem Cell 5:659-65 (2009). Flow Cyt ; Mouse . PubMed: 19951693
  • Wang YV  et al. Increased radioresistance and accelerated B cell lymphomas in mice with Mdmx mutations that prevent modifications by DNA-damage-activated kinases. Cancer Cell 16:33-43 (2009). WB ; Mouse . PubMed: 19573810
  • Masuda K  et al. Complex regulation of cell-cycle inhibitors by Fbxw7 in mouse embryonic fibroblasts. Oncogene : (2009). WB ; Mouse . PubMed: 20023701
  • Swarbrick A  et al. Id1 cooperates with oncogenic Ras to induce metastatic mammary carcinoma by subversion of the cellular senescence response. Proc Natl Acad Sci U S A 105:5402-7 (2008). WB ; Mouse . PubMed: 18378907
  • Seoane M  et al. Retinoblastoma loss modulates DNA damage response favoring tumor progression. PLoS One 3:e3632 (2008). WB ; Mouse . PubMed: 18985151
  • Suh HC  et al. Id1 immortalizes hematopoietic progenitors in vitro and promotes a myeloproliferative disease in vivo. Oncogene : (2008). WB . PubMed: 18542061
  • Bierings R  et al. An Endothelial Cell Genetic Screen Identifies the GTPase Rem2 as a Suppressor of p19ARF Expression That Promotes Endothelial Cell Proliferation and Angiogenesis. J Biol Chem 283:4408-16 (2008). WB ; Mouse . PubMed: 18056257
  • Suzuki A  et al. Tbx3 controls the fate of hepatic progenitor cells in liver development by suppressing p19ARF expression. Development 135:1589-95 (2008). IHC-P ; Mouse . PubMed: 18356246
  • Debies MT  et al. Tumor escape in a Wnt1-dependent mouse breast cancer model is enabled by p19Arf/p53 pathway lesions but not p16 Ink4a loss. J Clin Invest 118:51-63 (2008). WB ; Mouse . PubMed: 18060046
  • Yoneda-Kato N & Kato JY Shuttling imbalance of MLF1 results in p53 instability and increases susceptibility to oncogenic transformation. Mol Cell Biol 28:422-34 (2008). PubMed: 17967869
  • Calés C  et al. Inactivation of the polycomb group protein Ring1B unveils an antiproliferative role in hematopoietic cell expansion and cooperation with tumorigenesis associated with Ink4a deletion. Mol Cell Biol 28:1018-28 (2008). WB ; Mouse . PubMed: 18039844
  • Zimmerman RS & Rosenberg N Changes in p19Arf Localization Accompany Crisis During Pre-B Cell Transformation by Abelson Murine Leukemia Virus. J Virol : (2008). PubMed: 18579612
  • Chen YW  et al. p19Arf inhibits the invasion of hepatocellular carcinoma cells by binding to C-terminal binding protein. Cancer Res 68:476-82 (2008). WB ; Human . PubMed: 18199542
  • Yogev O  et al. DNA damage-dependent translocation of B23 and p19 ARF is regulated by the Jun N-terminal kinase pathway. Cancer Res 68:1398-406 (2008). WB, ICC/IF ; Mouse . PubMed: 18316603
  • Mudhasani R  et al. Loss of miRNA biogenesis induces p19Arf-p53 signaling and senescence in primary cells. J Cell Biol 181:1055-63 (2008). WB ; Mouse . PubMed: 18591425
  • Dance-Barnes ST  et al. Effects of mutant human Ki-ras(G12C) gene dosage on murine lung tumorigenesis and signaling to its downstream effectors. Toxicol Appl Pharmacol 231:77-84 (2008). IHC-P ; Mouse . PubMed: 18565564
  • Ueda Y  et al. Small mitochondrial ARF (smARF) is located in both the nucleus and cytoplasm, induces cell death, and activates p53 in mouse fibroblasts. FEBS Lett 582:1459-64 (2008). WB . PubMed: 18381074
  • Nishino J  et al. Hmga2 promotes neural stem cell self-renewal in young but not old mice by reducing p16Ink4a and p19Arf Expression. Cell 135:227-39 (2008). WB ; Mouse . PubMed: 18957199
  • Li X  et al. Oncogenesis of T-ALL and nonmalignant consequences of overexpressing intracellular NOTCH1. J Exp Med 205:2851-61 (2008). PubMed: 18981238
  • Esibizione D  et al. Candidate EDA targets revealed by expression profiling of primary keratinocytes from Tabby mutant mice. Gene 427:42-6 (2008). WB ; Mouse . PubMed: 18848976
  • Ansieau S  et al. Induction of EMT by twist proteins as a collateral effect of tumor-promoting inactivation of premature senescence. Cancer Cell 14:79-89 (2008). PubMed: 18598946
  • Labalette C  et al. The LIM-only protein FHL2 mediates ras-induced transformation through cyclin D1 and p53 pathways. PLoS One 3:e3761 (2008). WB . PubMed: 19018287
  • Poliseno L  et al. The proto-oncogene LRF is under post-transcriptional control of MiR-20a: implications for senescence. PLoS One 3:e2542 (2008). PubMed: 18596985
  • Vormer TL  et al. Anchorage-independent growth of pocket protein-deficient murine fibroblasts requires bypass of G2 arrest and can be accomplished by expression of TBX2. Mol Cell Biol 28:7263-73 (2008). PubMed: 18936168
  • Dohi Y  et al. Bach1 inhibits oxidative stress-induced cellular senescence by impeding p53 function on chromatin. Nat Struct Mol Biol 15:1246-54 (2008). PubMed: 19011633
  • Bouska A  et al. Mdm2 promotes genetic instability and transformation independent of p53. Mol Cell Biol 28:4862-74 (2008). PubMed: 18541670
  • Bagchi A  et al. CHD5 is a tumor suppressor at human 1p36. Cell 128:459-75 (2007). PubMed: 17289567
  • Ott RG  et al. JunB is a gatekeeper for B-lymphoid leukemia. Oncogene 26:4863-71 (2007). PubMed: 17297445
  • Chang DL  et al. ARF promotes accumulation of retinoblastoma protein through inhibition of MDM2. Oncogene 26:4627-34 (2007). PubMed: 17297463
  • Feldser DM & Greider CW Short telomeres limit tumor progression in vivo by inducing senescence. Cancer Cell 11:461-9 (2007). PubMed: 17433785
  • Bouchard C  et al. FoxO transcription factors suppress Myc-driven lymphomagenesis via direct activation of Arf. Genes Dev 21:2775-87 (2007). PubMed: 17974917
  • Kilbey A  et al. Runx2 disruption promotes immortalization and confers resistance to oncogene-induced senescence in primary murine fibroblasts. Cancer Res 67:11263-71 (2007). PubMed: 18056452
  • Miki J  et al. Polycomb complexes regulate cellular senescence by repression of ARF in cooperation with E2F3. Genes Cells 12:1371-82 (2007). PubMed: 18076574
  • Reimann M  et al. The Myc-evoked DNA damage response accounts for treatment resistance in primary lymphomas in vivo. Blood 110:2996-3004 (2007). PubMed: 17562874
  • Akli S  et al. Overexpression of the low molecular weight cyclin E in transgenic mice induces metastatic mammary carcinomas through the disruption of the ARF-p53 pathway. Cancer Res 67:7212-22 (2007). PubMed: 17671189
  • Andujar P  et al. Clinico-pathological features and somatic gene alterations in refractory ceramic fibre-induced murine mesothelioma reveal mineral fibre-induced mesothelioma identities. Carcinogenesis 28:1599-605 (2007). PubMed: 17272307
  • Sarkisian CJ  et al. Dose-dependent oncogene-induced senescence in vivo and its evasion during mammary tumorigenesis. Nat Cell Biol 9:493-505 (2007). WB ; Mouse . PubMed: 17450133
  • Morton JP  et al. RNA polymerase III transcription is repressed in response to the tumour suppressor ARF. Nucleic Acids Res 35:3046-52 (2007). WB ; Mouse . PubMed: 17439968
  • Gorrini C  et al. Tip60 is a haplo-insufficient tumour suppressor required for an oncogene-induced DNA damage response. Nature 448:1063-7 (2007). WB ; Mouse . PubMed: 17728759
  • Ji H  et al. LKB1 modulates lung cancer differentiation and metastasis. Nature 448:807-10 (2007). PubMed: 17676035
  • García MA  et al. Antiviral action of the tumor suppressor ARF. EMBO J 25:4284-92 (2006). PubMed: 16957780
  • Palacios G & Moll UM Mitochondrially targeted wild-type p53 suppresses growth of mutant p53 lymphomas in vivo. Oncogene 25:6133-9 (2006). PubMed: 16682948
  • Groisman I  et al. Control of cellular senescence by CPEB. Genes Dev 20:2701-12 (2006). PubMed: 17015432
  • Bardeesy N  et al. Smad4 is dispensable for normal pancreas development yet critical in progression and tumor biology of pancreas cancer. Genes Dev 20:3130-46 (2006). PubMed: 17114584
  • Finch A  et al. Bcl-xL gain of function and p19 ARF loss of function cooperate oncogenically with Myc in vivo by distinct mechanisms. Cancer Cell 10:113-20 (2006). PubMed: 16904610
  • Zeini M  et al. Specific contribution of p19(ARF) to nitric oxide-dependent apoptosis. J Immunol 177:3327-36 (2006). PubMed: 16920973
  • González L  et al. A functional link between the tumour suppressors ARF and p33ING1. Oncogene 25:5173-9 (2006). PubMed: 16607280
  • Gladden AB  et al. Expression of constitutively nuclear cyclin D1 in murine lymphocytes induces B-cell lymphoma. Oncogene 25:998-1007 (2006). PubMed: 16247460
  • Russell JL  et al. E2F1 suppresses skin carcinogenesis via the ARF-p53 pathway. Oncogene 25:867-76 (2006). PubMed: 16205640
  • Paliwal S  et al. Targeting of C-terminal binding protein (CtBP) by ARF results in p53-independent apoptosis. Mol Cell Biol 26:2360-72 (2006). WB ; Mouse . PubMed: 16508011
  • Wen R  et al. Essential role of phospholipase C gamma 2 in early B-cell development and Myc-mediated lymphomagenesis. Mol Cell Biol 26:9364-76 (2006). WB ; Mouse . PubMed: 17030619
  • Blyth K  et al. Runx2 and MYC collaborate in lymphoma development by suppressing apoptotic and growth arrest pathways in vivo. Cancer Res 66:2195-201 (2006). WB ; Mouse . PubMed: 16489021
  • Ringshausen I  et al. Mdm2 is critically and continuously required to suppress lethal p53 activity in vivo. Cancer Cell 10:501-14 (2006). PubMed: 17157790
  • McCabe MT  et al. Regulation of DNA methyltransferase 1 by the pRb/E2F1 pathway. Cancer Res 65:3624-32 (2005). PubMed: 15867357
  • Kawagoe H & Grosveld GC MN1-TEL myeloid oncoprotein expressed in multipotent progenitors perturbs both myeloid and lymphoid growth and causes T-lymphoid tumors in mice. Blood 106:4278-86 (2005). WB ; Mouse . PubMed: 16081688
  • Samuelson AV  et al. p400 is required for E1A to promote apoptosis. J Biol Chem 280:21915-23 (2005). WB ; Mouse . PubMed: 15741165
  • Hemann MT  et al. Evasion of the p53 tumour surveillance network by tumour-derived MYC mutants. Nature 436:807-11 (2005). WB ; Mouse . PubMed: 16094360
  • Chen Z  et al. Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis. Nature 436:725-30 (2005). IHC-P ; Mouse . PubMed: 16079851
  • Pauklin S  et al. ARF and ATM/ATR cooperate in p53-mediated apoptosis upon oncogenic stress. Biochem Biophys Res Commun 334:386-94 (2005). WB ; Mouse . PubMed: 16004968
  • Matheu A  et al. Regulation of the INK4a/ARF locus by histone deacetylase inhibitors. J Biol Chem 280:42433-41 (2005). PubMed: 16251190
  • Sebastian T  et al. C/EBPbeta cooperates with RB:E2F to implement Ras(V12)-induced cellular senescence. EMBO J 24:3301-12 (2005). PubMed: 16107878
  • Laud PR  et al. Elevated telomere-telomere recombination in WRN-deficient, telomere dysfunctional cells promotes escape from senescence and engagement of the ALT pathway. Genes Dev 19:2560-70 (2005). PubMed: 16264192
  • Lecomte C  et al. Similar tumor suppressor gene alteration profiles in asbestos-induced murine and human mesothelioma. Cell Cycle 4:1862-9 (2005). PubMed: 16319530
  • Chua KF  et al. Mammalian SIRT1 limits replicative life span in response to chronic genotoxic stress. Cell Metab 2:67-76 (2005). PubMed: 16054100
  • Cardone M  et al. The novel ETS factor TEL2 cooperates with Myc in B lymphomagenesis. Mol Cell Biol 25:2395-405 (2005). PubMed: 15743832
  • Nilsson JA  et al. Targeting ornithine decarboxylase in Myc-induced lymphomagenesis prevents tumor formation. Cancer Cell 7:433-44 (2005). PubMed: 15894264
  • Rowland BD  et al. The KLF4 tumour suppressor is a transcriptional repressor of p53 that acts as a context-dependent oncogene. Nat Cell Biol 7:1074-82 (2005). PubMed: 16244670
  • Ameyar-Zazoua M  et al. AP-1 dimers regulate transcription of the p14/p19ARF tumor suppressor gene. Oncogene 24:2298-306 (2005). PubMed: 15688012
  • Talos F  et al. Mitochondrially targeted p53 has tumor suppressor activities in vivo. Cancer Res 65:9971-81 (2005). PubMed: 16267022
  • Brady SN  et al. ARF impedes NPM/B23 shuttling in an Mdm2-sensitive tumor suppressor pathway. Mol Cell Biol 24:9327-38 (2004). PubMed: 15485902
  • Dannenberg JH  et al. Tissue-specific tumor suppressor activity of retinoblastoma gene homologs p107 and p130. Genes Dev 18:2952-62 (2004). PubMed: 15574596
  • Carnero A & Beach DH Absence of p21WAF1 cooperates with c-myc in bypassing Ras-induced senescence and enhances oncogenic cooperation. Oncogene 23:6006-11 (2004). PubMed: 15195145
  • Coré N  et al. Disruption of E2F signaling suppresses the INK4a-induced proliferative defect in M33-deficient mice. Oncogene 23:7660-8 (2004). PubMed: 15377996
  • Gil J  et al. Polycomb CBX7 has a unifying role in cellular lifespan. Nat Cell Biol 6:67-72 (2004). PubMed: 14647293
  • Danovi D  et al. Amplification of Mdmx (or Mdm4) directly contributes to tumor formation by inhibiting p53 tumor suppressor activity. Mol Cell Biol 24:5835-43 (2004). PubMed: 15199139
  • Wotton SF  et al. RUNX1 transformation of primary embryonic fibroblasts is revealed in the absence of p53. Oncogene 23:5476-86 (2004). PubMed: 15133495
  • Matheu A  et al. Increased gene dosage of Ink4a/Arf results in cancer resistance and normal aging. Genes Dev 18:2736-46 (2004). PubMed: 15520276
  • Kuo ML  et al. N-terminal polyubiquitination and degradation of the Arf tumor suppressor. Genes Dev 18:1862-74 (2004). PubMed: 15289458
  • Sandoval R  et al. Different requirements for the cytostatic and apoptotic effects of type I interferons. Induction of apoptosis requires ARF but not p53 in osteosarcoma cell lines. J Biol Chem 279:32275-80 (2004). PubMed: 15169789
  • Carneiro C  et al. p27 deficiency desensitizes Rb-/- cells to signals that trigger apoptosis during pituitary tumor development. Oncogene 22:361-9 (2003). PubMed: 12545157
  • Hurlin PJ  et al. Deletion of Mnt leads to disrupted cell cycle control and tumorigenesis. EMBO J 22:4584-96 (2003). PubMed: 12970171
  • Lindström MS & Wiman KG Myc and E2F1 induce p53 through p14ARF-independent mechanisms in human fibroblasts. Oncogene 22:4993-5005 (2003). PubMed: 12902982
  • Zindy F  et al. Arf tumor suppressor promoter monitors latent oncogenic signals in vivo. Proc Natl Acad Sci U S A 100:15930-5 (2003). PubMed: 14665695
  • Aguirre AJ  et al. Activated Kras and Ink4a/Arf deficiency cooperate to produce metastatic pancreatic ductal adenocarcinoma. Genes Dev 17:3112-26 (2003). PubMed: 14681207
  • Nakazawa Y  et al. ARF tumor suppressor induces mitochondria-dependent apoptosis by modulation of mitochondrial Bcl-2 family proteins. J Biol Chem 278:27888-95 (2003). PubMed: 12740365
  • Peeper DS  et al. A functional screen identifies hDRIL1 as an oncogene that rescues RAS-induced senescence. Nat Cell Biol 4:148-53 (2002). PubMed: 11812999
  • Dilla T  et al. The mdm2 proto-oncogene sensitizes human medullary thyroid carcinoma cells to ionizing radiation. Oncogene 21:2376-86 (2002). PubMed: 11948421
  • Lingbeek ME  et al. The T-box repressors TBX2 and TBX3 specifically regulate the tumor suppressor gene p14ARF via a variant T-site in the initiator. J Biol Chem 277:26120-7 (2002). PubMed: 12000749
  • Verschuren EW  et al. The oncogenic potential of Kaposi's sarcoma-associated herpesvirus cyclin is exposed by p53 loss in vitro and in vivo. Cancer Cell 2:229-41 (2002). PubMed: 12242155
  • Brummelkamp TR  et al. TBX-3, the gene mutated in Ulnar-Mammary Syndrome, is a negative regulator of p19ARF and inhibits senescence. J Biol Chem 277:6567-72 (2002). PubMed: 11748239
  • Palmero I  et al. Activation of ARF by oncogenic stress in mouse fibroblasts is independent of E2F1 and E2F2. Oncogene 21:2939-47 (2002). PubMed: 12082524
  • Tsuji K  et al. p53-independent apoptosis is induced by the p19ARF tumor suppressor. Biochem Biophys Res Commun 295:621-9 (2002). PubMed: 12099684
  • Higuchi M  et al. Expression of a conditional AML1-ETO oncogene bypasses embryonic lethality and establishes a murine model of human t(8;21) acute myeloid leukemia. Cancer Cell 1:63-74 (2002). PubMed: 12086889
  • Sotillo R  et al. Wide spectrum of tumors in knock-in mice carrying a Cdk4 protein insensitive to INK4 inhibitors. EMBO J 20:6637-47 (2001). PubMed: 11726500
  • Roper E  et al. p19ARF-independent induction of p53 and cell cycle arrest by Raf in murine keratinocytes. EMBO Rep 2:145-50 (2001). PubMed: 11258707
  • Peeper DS  et al. Escape from premature senescence is not sufficient for oncogenic transformation by Ras. Nat Cell Biol 3:198-203 (2001). PubMed: 11175753
  • Krimpenfort P  et al. Loss of p16Ink4a confers susceptibility to metastatic melanoma in mice. Nature 413:83-6 (2001). PubMed: 11544530
  • Baxter EW  et al. Selection for loss of p53 function in T-cell lymphomagenesis is alleviated by Moloney murine leukemia virus infection in myc transgenic mice. J Virol 75:9790-8 (2001). PubMed: 11559812
  • Lomax M & Fried M Polyoma virus disrupts ARF signaling to p53. Oncogene 20:4951-60 (2001). PubMed: 11526480
  • Sharpless NE  et al. Loss of p16Ink4a with retention of p19Arf predisposes mice to tumorigenesis. Nature 413:86-91 (2001). PubMed: 11544531
  • Tang DG  et al. Lack of replicative senescence in cultured rat oligodendrocyte precursor cells. Science 291:868-71 (2001). PubMed: 11157165
  • Jacobs JJ  et al. Senescence bypass screen identifies TBX2, which represses Cdkn2a (p19(ARF)) and is amplified in a subset of human breast cancers. Nat Genet 26:291-9 (2000). PubMed: 11062467
  • Pearson M  et al. PML regulates p53 acetylation and premature senescence induced by oncogenic Ras. Nature 406:207-10 (2000). PubMed: 10910364
  • Collado M  et al. Inhibition of the phosphoinositide 3-kinase pathway induces a senescence-like arrest mediated by p27Kip1. J Biol Chem 275:21960-8 (2000). PubMed: 10791951
  • Carnero A  et al. p16INK4A and p19ARF act in overlapping pathways in cellular immortalization. Nat Cell Biol 2:148-55 (2000). PubMed: 10707085
  • Dannenberg JH  et al. Ablation of the retinoblastoma gene family deregulates G(1) control causing immortalization and increased cell turnover under growth-restricting conditions. Genes Dev 14:3051-64 (2000). PubMed: 11114893
  • Beier R  et al. Induction of cyclin E-cdk2 kinase activity, E2F-dependent transcription and cell growth by Myc are genetically separable events. EMBO J 19:5813-23 (2000). PubMed: 11060032
  • Agami R & Bernards R Distinct initiation and maintenance mechanisms cooperate to induce G1 cell cycle arrest in response to DNA damage. Cell 102:55-66 (2000). PubMed: 10929713
  • Stout GJ & Blasco MA Genetic dissection of the mechanisms underlying telomere-associated diseases: impact of the TRF2 telomeric protein on mouse epidermal stem cells. Dis Model Mech 2:139-56 (0). PubMed: 19259387

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"

注册